About InVivoMAb anti-human c-myc
The 9E10 monoclonal antibody reacts with human c-myc, a 62 kDa transcription factor that plays a role in cell cycle progression, apoptosis and cellular transformation. Amplification of the c-myc gene has been found in several types of human cancers including lung, breast and colon carcinomas. c-Myc is commonly added to proteins of interest using recombinant DNA technology. The c-myc tag can then be used in many different assays that require recognition by an antibody.
InVivoMAb anti-human c-myc Specifications
Isotype | Mouse IgG1 |
Recommended Isotype Control(s) | InVivoMAb mouse IgG1 isotype control, unknown specificity(BE0083) |
Recommended InVivoPure Dilution Buffer | InVivoPure pH 7.0 Dilution Buffer(IP0070) |
Immunogen | C-terminal peptide of human c-myc (aa 408-439) |
Reported Applications |
|
Endotoxin |
|
Purity |
|
Formulation |
|
Sterility | 0.2 μM filtered |
Production | Purified from tissue culture supernatant in an animal free facility |
Purification | Protein G |
Storage | The antibody solution should be stored at the stock concentration at 4°C. Do not freeze. |
RRID | AB_2687720 |
Molecular Weight | 150 kDa |